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Aging is associated with functional alterations of synapses thought to contribute to age-dependent 
memory impairment (AMI). While therapeutic avenues to protect from AMI are largely elusive, 
supplementation of spermidine, a polyamine normally declining with age, has been shown to restore 
defective proteostasis and to protect from AMI in Drosophila. Here we demonstrate that dietary 
spermidine protects from age-related synaptic alterations at hippocampal mossy fiber (MF)-CA3 
synapses and prevents the aging-induced loss of neuronal mitochondria. Dietary spermidine rescued 
age-dependent decreases in synaptic vesicle density and largely restored defective presynaptic MF-CA3 
long-term potentiation (LTP) at MF-CA3 synapses (MF-CA3) in aged animals. In contrast, spermidine 
failed to protect CA3-CA1 hippocampal synapses characterized by postsynaptic LTP from age-related 
changes in function and morphology. our data demonstrate that dietary spermidine attenuates age-
associated deterioration of MF-CA3 synaptic transmission and plasticity. These findings provide a 
physiological and molecular basis for the future therapeutic usage of spermidine.
Aging is the major risk factor driving age-dependent memory impairment (AMI) even in the absence of neuro-
degenerative diseases, representing one of the top health burden of the 21st century1. Rather than gross neuronal 
loss characteristic of neurodegenerative diseases2, AMI is associated with subtle but selective and region-specific 
changes such as dysregulation in synapse number and structure, dendrite morphology, cellular connectivity and/
or Ca2+ homeostasis3–5. Aging has also been postulated to be associated with a decline in autophagy/lysosomal 
proteolysis, a cytoprotective degradation pathway responsible for the turnover of long-lived aggregate-prone pro-
teins and damaged organelles (importantly mitochondria). Autophagy is considered to exert protective func-
tions against aging and age-associated diseases6. Irrespective of the exact and potentially complex relation of 
aging and protective programs such as autophagy, stimulation of autophagy has been proposed to protect from 
aging effects in various models7–9. We have previously demonstrated that feeding fruit flies with the naturally 
occurring polyamine spermidine, whose levels decline with age in a broad spectrum of organisms likely includ-
ing humans7,9–12, protects from AMI. Spermidine supplementation counteracts ultrastructural and functional 
changes at aging synapses via a mechanism that requires a functional autophagy machinery9,11. First analysis 
in aging mice has shown that spermidine feeding prolongs life span and exerts cardioprotective effects7,13 by 
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Figure 1. Spermidine treatment increases LC3 and WIPI2 levels while reducing p62 in aged hippocampal 
neurons. (a) Confocal images of LC3 immunoreactivity in the dentate gyrus granule cell layer (GL) of young 
(5 months old), aged control (24 months old) and aged spermidine treated (18 + 6 months) mice. (b) GL 
LC3 integrated density (young: 100 ± 13, n = 14 mice; aged Spd−: 72 ± 9, n = 10 mice; aged Spd +: 134 ± 21, 
n = 12 mice, aged Spd− versus aged Spd+: p = 0.026907, one-way ANOVA with Tukey post-hoc test). (c) 
Representative confocal images of LC3 immunoreactivity in the CA3 stratum lucidum (SL) of young, aged 
control and aged spermidine treated mice. (d) SL LC3 integrated density (young: 100 ± 12, n = 14 mice; aged 
Spd−: 88 ± 9, n = 10 mice; aged Spd+: 172 ± 32, n = 12 mice; aged Spd− versus aged Spd +: p = 0.013770, 
Kruskal-Wallis test followed by Mann Whitney U test with Bonferroni correction with α set to 0.016667). 
Results represent 1–2 technical replicates. (e) Confocal images of WIPI2 immunoreactivity in the CA3 SL of 
young, aged control and aged spermidine treated mice. (f) SL WIPI2 integrated density (young: 100 ± 24, n = 14 
mice; aged Spd−: 88 ± 22, n = 10; aged Spd+: 159 ± 29, n = 12 mice; young versus aged Spd+: p = 0.012670, 
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autophagic reprogramming13,14. Interestingly, a recent pilot trial study indicates that spermidine might exert ben-
eficial effects on cognitive performance in elderly humans at risk of dementia15. Thus, taken together, spermidine 
is a promising candidate for anti-AMI interventions.
Synaptic plasticity in the hippocampus, a pivotal cortical area for learning and memory, is particularly sensi-
tive to aging16,17 and age-induced impairment of hippocampus-dependent memories in mice has been suggested 
to be linked to the downregulation of select autophagy factors8,18. Two well-studied types of hippocampal syn-
apses are the (i) mossy fiber (MF)-CA3 synapses formed by dentate granule cell (DG) axons onto CA3 pyramidal 
neurons and (ii) the CA3-CA1 synapses of the Schaffer collateral pathway. MF-CA3 and CA3-CA1 Schaffer col-
lateral synapses display distinct pre- and postsynaptic forms of long-term potentiation (LTP), respectively19, and, 
hence, might be differentially affected by dietary spermidine in aging animals.
Here we show that both types of hippocampal synapses suffer from an aging-induced decrease in synaptic ves-
icle (SV) density and mitochondria abundance. Dietary spermidine supplementation protected from age-related 
synaptic alterations and partially restored defective LTP selectively at hippocampal mossy fiber (MF)-CA3 but not 
CA3-CA1 synapses while preventing the aging-induced loss of neuronal mitochondria at both types of synapses. 
Our results unravel synapse-specific beneficial effects of spermidine at hippocampal synapses characterized by 
differential synaptic plasticity, thereby providing information for the future development of potential therapies 
against AMI.
Results
Dietary spermidine supplementation age-protects autophagy in the mouse hippocampal CA3 
area. Based on previous studies demonstrating that spermidine supplementation stimulates autophagy7,20, 
we set up several independent cohorts of aged mice undergoing a six-months long spermidine treatment in their 
drinking water, starting at 18 months of age. To determine if spermidine (Spd) treatment was able to protect 
from aging-induced decline of autophagy, we analyzed the expression levels of the key autophagy protein LC3 
in the hippocampus of young, aged Spd− (24 months old) and aged Spd+ (18 + 6 months) mice. We focused on 
hippocampal granule cells that form MF synapses onto CA3 pyramidal neurons. In the dentate gyrus granule cell 
body layer, aging tended to decrease LC3 levels. Importantly, these levels were significantly increased by spermi-
dine treatment (Fig. 1a,b). Similar observations were made in the CA3 stratum lucidum area, where granule cells 
form MF-CA3 synapses. Akin to the dentate gyrus LC3 levels also tended to decline with age in the synaptic CA3 
area, while spermidine treatment led to a significant increase in LC3 expression (Fig. 1c,d). These data suggest 
that dietary spermidine indeed boosts the steady-state levels of the key autophagy protein LC3 in hippocampal 
granule cells.
Next, we analyzed the expression levels of WIPI2, an essential autophagy protein whose overexpression 
restores autophagosome biogenesis in aged dorsal root ganglion neurons21. Notably, WIPI2 immunoreactivity 
appeared particularly pronounced in the stratum lucidum (SL), e.g. a region where MFs are located (Fig. 1e). 
In the CA3 SL spermidine treatment tended to increase WIPI2 levels compared to identically aged controls 
(Fig. 1e,f) and WIPI2 levels were significantly upregulated in the spermidine treated cohort in comparison to 
young control mice (Fig. 1e,f).
Reduced autophagic protein turnover is typically associated with the accumulation of p62, an autophagy 
receptor for aggregated proteins that itself is a substrate for autophagy8. Although the number and size of p62 
puncta was highly variable in aged mice, we found that spermidine treatment significantly reduced the p62 spot 
area as compared to aged matched non-spermidine treated controls (Fig. 1g–i). Collectively, these data suggest 
that dietary spermidine may indeed promote autophagy in the mouse hippocampal CA3 area in vivo.
Dietary spermidine stabilizes and protects mitochondria at aging hippocampal syn-
apses. Mitophagy, a specialized form of selective autophagy, is an essential mechanism for the long-term 
maintenance and protection of mitochondrial abundance and functional integrity. Spermidine previously was 
found to activate the degradation of dysfunctional mitochondria by mitophagy in the heart7. We therefore ultra-
structurally analyzed mitochondria in presynaptic terminals of MF-CA3 synapses (Fig. 2a–d). Although aging 
did not alter the percentage of mossy fiber boutons containing at least one mitochondrion (Fig. S1a), the density 
of mitochondria in aged mossy fiber boutons was significantly decreased compared to MFBs of young adult 
mice (Fig. 2b), confirming previous observations at mossy fiber boutons of aged rats22. Dietary spermidine res-
cued the age-dependent decrease in mitochondria density at mossy fiber boutons (Fig. 2b), without affecting 
the fraction of boutons containing mitochondria (Fig. S1a). Interestingly, adult MF terminals often displayed 
several mitochondria arranged in local networks (Fig. S1b), while in aged mossy fiber boutons such networks 
tended to decrease (Fig. S1b). Instead, individual mitochondria appeared enlarged, a feature typically associated 
with a dysfunctional state (Fig. 2a–d). Aging previously was reported to lead to increases in mitochondrial size 
(“swelling”)23, a feature that we also observed in our aged cohort (Fig. 2a,d). Spermidine treatment appeared to 
Kruskal-Wallis test followed by Mann Whitney U test with Bonferroni correction with α set to 0.016667). (g) 
Confocal images of p62 immunoreactivity in the CA3 pyramidal layer (PL) of young, aged control and aged 
spermidine treated mice. (h) PL p62 spots number normalized to young controls (young: 100 ± 24, n = 10 mice; 
aged Spd−: 148 ± 68, n = 6 mice; aged Spd+:130 ± 69, n = 7 mice). (i) PL p62 spots area normalized to young 
controls (young: 100 ± 3; aged Spd−: 111 ± 5; aged Spd+: 91 ± 5; aged Spd− versus aged Spd+: p = 0.013986, 
Kruskal-Wallis test followed by Mann Whitney U test with Bonferroni correction with α set to 0.016667). ROIs 
indicate the area quantified within each image. *p < 0.05. Values represent mean ± SEM. Graphs show medians, 
interquartile ranges and min/max values. Circles are outliers and pentagons are extremes.
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Figure 2. Spermidine protects from age-induced alterations in mitochondria at MF-CA3 synapses by 
increasing mitochondrial mass. (a–d) Ultrastructural analysis of Mossy Fiber (MF) terminals. MF bouton 
area is highlighted in light blue, spiny excrescences in yellow. (b) Mitochondria density in MF boutons 
(p = 0.0046, aged Spd−:1.04 ± 0.09, n = 67 boutons, aged Spd+: 1.65 ± 0.14, n = 64 boutons; p = 0.0142, 
young: 1.69 ± 0.16, n = 60 boutons, versus aged Spd−, 6 mice/group, two samples Kolmogorov-Smirnov test 
with Bonferroni correction with α set to 0.016667). (c) MF bouton area covered by mitochondria (young: 
8.5 ± 0.8, n = 55 boutons; aged Spd−: 6.9 ± 0.6, n = 58 boutons; aged Spd+: 8.4 ± 0.6, n = 56 boutons, 6 mice/
group). (d) Average visible mitochondrial area (p = 0.011849, aged Spd−: 0.059 ± 0.003, n = 58 boutons, aged 
Spd+: 0.050 ± 0.003, n = 56 boutons; p = 0.000580, young: 0.046 ± 0.002, n = 55 boutons, versus aged Spd−, 
6 mice/group, Kruskal-Wallis test followed by Mann Whitney U test with Bonferroni correction with α set 
to 0.016667). (e–g) Ultrastructural analysis of presynaptic CA3-CA1 terminals. (f) Percentage of CA3-CA1 
presynaptic terminals containing at least one mitochondrion (young: 15 ± 2, n = 6 mice, 180 boutons; aged 
Spd−: 11 ± 2, n = 7 mice, 210 boutons; aged Spd+: 23 ± 5 n = 6 mice, 180 boutons; aged Spd− versus aged 
Spd+: p = 0.023280, one-way ANOVA with Tukey post-hoc test). (g) Percentage of bouton area covered by 
mitochondria (young: 3.4 ± 0.5, n = 6 mice, 180 boutons analyzed; aged Spd−: 2.6 ± 0.5, n = 7 mice, 210 
boutons; aged Spd+: 4.9 ± 0.9, n = 6 mice, 180 boutons). (h) Relative mitochondrial DNA content in brains 
of young (100 ± 4, n = 9 mice), aged Spd− (106 ± 9, n = 12 mice) and aged Spd + mice (144 ± 14, n = 10 
mice), normalized to young controls (young versus aged Spd+: p = 0.021083; aged Spd + versus aged Spd−: 
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protect from this age-induced swelling phenotype and tended to rescue network formation (Figs. 2a,d and S1b). 
When analyzing the relative bouton area covered by mitochondria in presynaptic MF terminals, we observed a 
trend towards rejuvenated values in the spermidine supplemented animals (Fig. 2c), though not to statistical sig-
nificance. To see whether a similar protective effect of spermidine can be observed at other types of hippocampal 
synapses, we analyzed mitochondrial abundance at CA3-CA1 presynaptic terminals (Fig. 2e–g). At this synapse 
type, age tended to decrease the number of boutons containing at least one mitochondrion (Fig. 2f). Spermidine 
treatment significantly increased the fraction of mitochondria-containing boutons (Fig. 2f) and also tended to 
increase the bouton area covered by mitochondria (Fig. 2g).
Finally, we asked whether the observed increase in presynaptic mitochondrial abundance by spermidine treat-
ment was associated with an overall increase in mitochondrial mass. To probe this, we performed quantitative 
real time qPCR to measure mitochondrial DNA content of young, aged mock, and aged spermidine-treated brain 
tissue (Fig. 2h). Analysis of the abundance of mitochondrial DNA (normalized to nuclear β actin DNA) revealed 
a high variability in aged mice in comparison to young controls. Spermidine treatment significantly increased the 
relative mitochondrial DNA abundance in comparison to aged mice and young controls (Fig. 2h), indicating that 
spermidine supplementation can indeed increase net mitochondrial mass.
Taken together, our analyses demonstrate that chronic dietary spermidine supplementation results in 
age-protection of mitochondria at sites of neurotransmitter release of both MF-CA3 and CA3-CA1 synapses via 
an overall increase in mitochondrial mass.
Aging effects on MF-CA3 synapse ultrastructure are responsive to spermidine supplementa-
tion. Next we asked whether aging promotes changes in ultrastructure at mossy fiber synapses onto CA3 
pyramidal neurons (MF-CA3; Fig. 3) and CA3-CA1 synapses (Fig. 4). MF-CA3 synapses display multiple release 
sites, large paired-pulse and frequency facilitation19,24,25 and marked synaptic plasticity of presynaptic origin19,26. 
MF-CA3 synapses thus markedly differ from CA3-CA1 synapses, the vast majority of which form a single syn-
aptic contact27. Structural changes at MF-CA3 release sites during aging might therefore conceivably underlie 
age-dependent alterations in synaptic plasticity at this synapse. EM analysis of the ultrastructure of aged hip-
pocampal MF-CA3 synapses revealed a significant reduction in synaptic vesicle (SV) density by approximately 
30% when compared to synapses from young control mice, while the area occupied by mossy fiber boutons 
remained unchanged (Fig. 3a–c), similar to previous reports for mossy fiber boutons in aged rats22. While aging 
did not significantly alter the density of active zones (Fig. 3d), the length of individual active zones also signifi-
cantly decreased with age (Fig. S2). Importantly, spermidine treatment for 6 months rescued the age-dependent 
reduction in SV density of aged MF-CA3 synapses to the density observed in young animals (Fig. 3b). Spermidine 
did not affect active zone number or active zone length when compared to age-matched controls (Figs. 3d, S2).
To see whether a similar protective effect of spermidine is observed at other types of hippocampal synapses, 
we analyzed the ultrastructure of CA3-CA1 presynaptic terminals (Fig. 4a–d). This widely investigated synapse 
executes long-term synaptic plasticity postsynaptically28. Consistent with our findings at MF-CA3 synapses, we 
found that aging decreased SV density at CA3-CA1 synapses (Fig. 4b). In contrast to MF-CA3 synapses treatment 
with spermidine for 6 months did not rescue these changes (Fig. 4a,b). The visible presynaptic bouton profile 
tended to increase in aged control and spermidine treatment significantly increased it (Fig. 4c), suggesting that 
spermidine may not be able to counteract aging-induced alterations in presynaptic bouton size of CA3-CA1 syn-
apses. Similarly, aging tended to be associated with a slightly increased active zone (AZ) length, which could not 
be reversed by spermidine treatment (Fig. 4d).
Collectively, these data show that dietary spermidine supplementation selectively prevents aging-induced loss 
of SVs at MF-CA3 but not CA3-CA1 synapses in the mouse hippocampus.
Dietary spermidine age-protects long-term plasticity specifically at MF-CA3 synapses. Given 
these encouraging results, we investigated whether the observed protective effects of spermidine with respect 
to MF-CA3 synapse ultrastructure would translate into the preservation of synaptic function and plasticity. We 
therefore analyzed long-term potentiation (LTP), a cellular paradigm for information storage, learning and mem-
ory28, at MF-CA3 synapses. LTP has been reported to decline with age at hippocampal synapses29,30, includ-
ing MF-CA3 synapses31. Indeed, when we analyzed acute hippocampal slices from aged mice (24 months) by 
field recordings (Fig. 5a), we observed a severe reduction of MF-LTP in comparison to young adult mice (5 
months; Fig. 5b,c). Frequency facilitation, a form of short term plasticity pronounced at MF-CA3 synapses in 
which a switch from low to modest stimulation frequencies lead to an increase in synaptic strength19, was unal-
tered (Fig. S3). Importantly, we found that spermidine supplementation significantly rescued the age-dependent 
decrease of MF-LTP in 24 months-old animals (Fig. 5b,c). When we analyzed EPSP/fiber volley curves, we 
observed an age-dependent increase in basal neurotransmission at MF-CA3 synapses that, similar to LTP, was 
rescued to juvenile levels by spermidine treatment (Fig. 5d,e). As a control we also studied CA3-CA1 synapses 
that exhibit largely postsynaptic forms of LTP. Consistent with previous studies29,30, we observed a trend towards 
lower LTP of fEPSP slopes at CA3-CA1 synapses of aged animals (Fig. 6a,b). Chronic spermidine administration 
did not rescue this trend towards an age-dependent decrease in CA3-CA1 LTP (Fig. 6b), consistent with the 
lack of effect of spermidine with respect to SV density (Fig. 4b). When we analyzed CA3-CA1 EPSP/fiber volley 
p = 0.036320, one-way ANOVA with Tukey post-hoc test). Relative mitochondrial DNA abundance was 
determined by measuring mitochondrial cytochrome B DNA content relative to nuclear DNA content (β actin). 
*p < 0.05, **p < 0.01. Values represent mean ± SEM. Graphs show medians, interquartile ranges and min/max 
values. Circles are outliers and triangles are extremes. Black arrows indicate mitochondria.
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curves, we did not observe any significant changes with either aging or spermidine treatment (Fig. 6c,d). Taken 
together, our results reveal a synapse-specific restoration of presynaptic LTP at MF-CA3 synapses by dietary 
spermidine in aged mice.
Discussion
Elucidating the cellular and molecular mechanisms that underlie the aging of brain function are a major chal-
lenge of neuroscience. Finding dietary regimes to fundamentally reduce the rate at which these processes occur 
is equally relevant. Recent reports suggest that with aging neuronal autophagy might decline6,8 and, importantly, 
that restoring hippocampal autophagy in aged mice allows for a rescue of age-induced memory impairment8,32. 
In the present study, we show that dietary supplementation of spermidine, a substance usually declining with age, 
can restore levels of core autophagic proteins. We found that spermidine treatment for 6 months starting late in 
life (at 18 months), a feeding scheme previously shown to extend life-span of aged mice7, enhanced clearance of 
the autophagy substrate p62 and increased expression of key autophagy proteins (LC3, WIPI2). These data are 
consistent with previous studies in other organ systems demonstrating that spermidine administration can stimu-
late autophagic flux20,33–35 and a prominent autophagic role for WIPI2 in aged neurons21. These data thus indicate 
that chronic spermidine supplementation might promote autophagy in the aged mouse brain.
Age-dependent cognitive decline seems to be tightly associated with subtle synaptic changes but is not man-
datorily linked to neuronal cell death3, a prominent feature of neurodegenerative disorders rather than normal 
aging. Changes in the density of the pool of synaptic vesicles distant from active zones (e.g. the recycling and 
reserve pools) have been previously described at hippocampal Schaffer collateral synapses of aged rats36 and at 
MF-CA3 synapses22. Our data confirm that aging indeed leads to decreased SV density at both MF-CA3 and 
CA3-CA1 synapses (Figs. 3a,b and 4a,b). Most importantly, we found that spermidine treatment late in life could 
rescue the age-dependent reduction in SV density and in LTP at MF-CA3 synapses. Strikingly, this phenotype 
was synapse-specific as spermidine administration failed to elicit postsynaptic LTP at and to restore SV density 
at CA3-CA1 synapses (Figs. 5b,c and 6b). Spermidine supplementation also rescued the age-dependent increase 
in EPSP/fiber volley amplitudes observed at MF-CA3 synapses (Fig. 5d,e), which might indicate higher basal 
neurotransmission at these synapses with age, as previously reported for aged synapses in the Drosophila olfac-
tory circuitry11. Our results are in contrast with a recent study at aged MF-CA3 synapses in rats using 4-6 week 
Figure 3. Spermidine treatment rescues the age-dependent decrease in SV density selectively at MF-
CA3 synapses. (a–d) Ultrastructural analysis of Mossy Fiber (MF) terminals. (a) Representative electron 
micrographs of MF boutons. Note the reduction in SV density in an aged Spd− bouton (black asterisk). MF 
bouton visible area is highlighted in light blue, spiny excrescences are highlighted in yellow. (b) Synaptic vesicles 
(SV) density (p = 0.0004, aged Spd−: 128.26 ± 5.11, n = 67 boutons, versus aged Spd+: 159.43 ± 5.05, n = 64; 
p = 0.0008, young: 163.03 ± 6.86, n = 60, versus aged Spd−; 6 mice/group; two samples Kolmogorov-Smirnov 
test Bonferroni corrected with α set to 0.016667). (c) Visible bouton profile indicating the synaptic bouton area 
visible within each image (aged Spd−: 2.69 ± 0.09, aged Spd+: 2.34 ± 0.10, young: 2.43 ± 0.13). (d) Active zone 
(AZ) density (aged Spd−: 2.41 ± 0.15, aged Spd+: 2.62 ± 0.16, young: 2.65 ± 0.19). Arrowheads indicate active 
zones, note an active zone with drastically reduced neighboring SVs in the representative electron micrograph 
of an aged control mouse. Values represent mean ± SEM. Graphs show medians, interquartile ranges and min/
max values, circles are outliers.
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old animals as young controls31, which might reflect developmental changes still occurring at this early age. The 
discrepancy might be due to the different species and age windows used.
Different from CA3-CA1 synapses, MF-CA3 synapses are characterized by presynaptic plasticity, a process 
controlled by presynaptic cAMP and cAMP-dependent protein kinase (PKA) via Rab3a, a SV protein that regu-
lates SV fusion19,37,38. Interestingly, we observed similar beneficial effects of spermidine at Drosophila mushroom 
body synapses that are also characterized by cAMP-driven presynaptic plasticity to form new memories9,11,39. Our 
results might indicate that spermidine acts on a mechanism that specifically regulates the SV pool at MF termi-
nals. This is not unlikely considering that MF-CA3 synapses are remarkably different in term of structure, release 
probability and plasticity from CA3-CA1 synapses19,24–27,40. MF-CA3 synapses display multiple release sites, low 
release probability41, strong facilitation and execute long term plasticity via presynaptic mechanisms. In contrast, 
CA3-CA1 synapses form a single synaptic contact and are characterized by higher release probability42,43. Past 
studies have demonstrated a differential regulation or role of proteins involved in SV cycling at MF-CA3 versus 
CA3-CA1 synapses, supporting our findings. The Rab3-interacting protein Rabphilin is a PKA effector, that con-
trols the recovery of the ready releasable pool (RRP) of SVs following extensive synaptic activity44. Active PKA 
has been shown to differentially phosphorylate Rabphilin at MF vs. CA3-CA1 synapses, suggesting a MF-specific 
mechanism regulating SVs exocytosis upon RRP depletion45. We thus speculate that spermidine might exert ben-
eficial effects specifically at synapses executing synaptic plasticity via presynaptic mechanisms, possibly including 
autophagic turnover of presynaptic components. While these mechanisms may be complex, our data showing 
that spermidine supplementation prevents aging-induced defects in presynaptic mitochondria (Fig. 2), suggests 
a possible role for mitochondrial maintenance in presynaptic Ca2+ homeostasis46–48. Interestingly, spermidine 
has been found to increase the rate and affinity of Ca2+ uptake in brain mitochondria49. This may be of particular 
importance for pre- but not postsynaptic forms of LTP, i.e. at MF-CA3 synapses. Future studies will be needed to 
address this possibility. We would like to note that effects of spermidine on CA1 mitochondrial morphological 
parameters could not be observed in another cohort with very different housing conditions (smaller group size, 
different environmental enrichment) in a different animal facility which also showed less clear aging effects (data 
not shown). This suggests that environmental factors can impinge on neuronal ultrastructure of the aging brain 
per se or on the effects of spermidine in particular. Defining these factors should also be subject of future research.
Figure 4. Spermidine treatment does not rescue the age-dependent decrease in SV density at CA3-CA1 
synapses. (a–d) Ultrastructural analysis of presynaptic CA3-CA1 terminals, whose visible area is here 
highlighted in light blue. (a) Representative electron micrographs of CA3-CA1 synapses. Note the reduction in 
SV density in an aged Spd− bouton (black asterisk). (b) Synaptic vesicle (SV) density (young: 175 ± 5, n = 180 
boutons, 6 mice analyzed; aged Spd−: 136 ± 4, n = 210, 7 mice; aged Spd+: 130 ± 4, n = 180, 6 mice; young 
versus aged Spd−: p < 0.0001; young versus aged Spd+: p < 0.0001, two samples Kolmogorov-Smirnov test 
Bonferroni corrected with α set to 0.016667). (c) Visible bouton profile indicating the synaptic bouton area 
visible within each image (young: 0.135 ± 0.006, aged Spd−: 0.166 ± 0.008, aged Spd+: 0.173 ± 0.008; young 
versus aged Spd+: p = 0.000106, Kruskal-Wallis test followed by Mann Whitney U test Bonferroni corrected 
with α set to 0.016667). (d) Active zone (AZ) length (young: 260 ± 7, aged Spd−: 280 ± 7, aged Spd+: 287 ± 7; 
young versus aged Spd+: p = 0.002623, Kruskal-Wallis test followed by Mann Whitney U test Bonferroni 
corrected with α set to 0.016667). **p < 0.01, ***p < 0.001. Arrowheads indicate active zones, note an active 
zone with drastically reduced neighboring SVs in the representative electron micrograph of an aged control 
mouse. Values represent mean ± SEM. Graphs show medians, interquartile ranges and min/max values. Circles 
are outliers and pentagons are extremes.
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Taken together, we provide a direct demonstration of the beneficial effects of dietary spermidine supplemen-
tation in an electrophysiological paradigm of learning in a mammalian model. Our findings may, thus, be of 
importance for the development of future therapies against AMI.
Figure 5. Spermidine treatment rescues the age-dependent decrease in LTP selectively at MF-CA3 synapses 
while restoring their EPSP/fiber volley curves. (a) Scheme of electrophysiological recordings at MF-CA3 
synapses, depicting stimulation (S), recording (R) electrode. (b) HFS induced LTP of MF-fEPSPs in young 
(143.1 ± 2.7), aged (114.9 ± 2.5) and spermidine treated mice (130.1 ± 4.5) and averaged MF-fEPSPs collected 
before (black), 45–60 min after LTP induction (gray) and after application of the agonist of type II metabotropic 
glutamate receptors DCG IV (2 µM; dark gray). Only responses inhibited by 70–80% and more were assumed 
to be elicited by mossy fiber synapses. Calibration: 0.3 mV, 5 ms. (c) LTP levels 45–60 min after induction. 
Young: n = 12 slices N = 6 mice, aged Spd−: n = 13 N = 7, aged Spd+: n = 10 N = 6 (p = <0.001, One-way 
RM ANOVA with Shapiro-Wilk post-hoc test: young versus aged Spd−: p < 0.001, aged Spd− versus aged 
Spd+: p = 0.002, young versus aged Spd+: p = 0.002). (d) Correlation of MF-fEPSP amplitude and FV (fiber 
volley; ANCOVA: p = 0.0003) and representative average traces of MF-fEPSPs with FVs, scaled to similar FV 
amplitude. Calibration: 0.2 mV, 5 ms. Several stimulation intensities (0–500 µA) were used to record different FV 
amplitudes (young: 67 data points; aged Spd−: 68; aged Spd+: 58). (e) Average fEPSP/FV values for each slice 
(young: 0.79 ± 0.08; aged Spd−; 1.19 ± 0.11; aged Spd+: 0.76 ± 0.81; young versus aged Spd−: p = 0.011342; 
aged Spd− versus aged Spd+: p = 0.000997, Kruskal-Wallis test followed by Mann Whitney U test Bonferroni 
corrected with α set to 0.016667). Young: n = 22 N = 9; aged Spd−: n = 36 N = 14; aged Spd+: n = 33 N =  = 16. 
*p < 0.05, **p < 0.01, ***p < 0.001. Values and graphs as in Fig. 3.
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Material and Methods
Spermidine supplementation. C57BL6 WT mice were purchased from Janvier Labs (C57BL/6 J:Rj males). 
Spermidine supplementation at a final concentration of 3 mM in drinking water started late in life (18 months of 
age) for 6 months7. A more detail description of housing conditions is found in the Supplemental Information. 
Notably, the effects of spermidine on CA1 mitochondrial morphological parameters were not observed in another 
cohort with very different housing conditions (smaller group size, different environmental enrichment) in a dif-
ferent animal facility (data not shown),
All animal experiments were approved by the animal welfare committee of Charité Universitätsmedizin 
Berlin, Leibniz Institut für Molekulare Pharmakologie (FMP) and the Landesamt für Gesundheit und Soziales 
Berlin and by the Bundesministerium für Wissenschaft, Forschung und Wirtschaft, BMWFW, Austria: BMWF-
66.007/0011-II/3b/2013, BMWFW-66.007/0002-WF/V/3b/2015. All experiments were performed in accordance 
with the relevant guidelines and regulations.
Figure 6. Spermidine treatment does not rescue the age-dependent decrease in LTP at CA3-CA1 synapses. 
(a) Scheme of electrophysiological recordings at hippocampal CA3-CA1 synapses, depicting stimulation (S), 
recording (R) electrode (Dentate gyrus - DG, CA3 and CA1). (b) Time course of LTP induction in CA3-CA1 
synapses and average baseline fEPSPs (black) for 10 min before LTP induction and potentiated fEPSPs (gray), 
50–60 min after. Young: 145.8 ± 6.9, n = 13 slices N = 5 mice; aged Spd−: 130.6 ± 7.6, n = 10 N = 4; aged Spd+: 
123.2 ± 5.4, n = 13 N = 6 (p = 0.0504, One-way ANOVA). Calibration: 0.2 mV, 5 ms. (c) Correlation of fEPSP 
slope and FV (fiber volley) at CA3-CA1 synapses (ANCOVA: p = 0.5754) and average traces of CA3-CA1-
fEPSPs with FVs, scaled to similar FV amplitude. Calibration: 0.2 mV, 5 ms. Several stimulation intensities 
(0–500 µA) were used to record different FV amplitudes; each data point represents the average values for one 
stimulation intensity (young: 72 data points; aged Spd−: 70 data points; aged Spd+: 85 data points). (d) Average 
CA3-CA1 fEPSP slope/FV values for each slice (young: 1.791 ± 0.26, n = 13 N = 5, aged Spd−: 1.521 ± 0.14, 
n = 10 N = 4, aged Spd+: 1.707 ± 0.17, n = 14 N = 6; p = 0.7645, Kruskal-Wallis test). Values and graphs as in 
Fig. 4.
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immunohistochemistry. For immunostaining, 30 µm thick coronal hippocampal sections from all groups 
were processed simultaneously. Following permeabilization, sections were preincubated with 0.125 M PB con-
taining 5% (vol/vol) donkey serum and 0.3% Triton X-100 (TX-100) for 1 h. Sections were incubated with pri-
mary antibodies diluted in 0.3% TX-100 at 4 °C for 48 h, then washed and incubated in secondary antibodies for 
2 h, RT. A detailed description of the immunohistochemical procedure is listed in the Supplemental Information.
electron microscopy. Following transcardial perfusion with a mixture of 2% formaldehyde (FA) and 2% 
glutaraldehyde in 0.1 M phosphate buffer (PB, pH 7.4) under anesthesia, brains were post-fixed overnight in 
4% FA at 4 °C. Ultrathin sections were examined with a JEM-1011 transmission electron microscope (JEOL, 
Tokyo, Japan). Data collection was performed blindly. A more detail description is found in the Supplemental 
Information.
Ultrastructural analysis. We analyzed six-seven mice per group. Visible bouton area, synaptic vesicles, 
active zones, mitochondria and their visible area were manually annotated in ImageJ (1.48 v). A more detail 
description is found in the Supplemental Information.
electrophysiology. For recordings of MF-fEPSPs and CA3-CA1 fEPSP, mice were anesthetized with iso-
flurane overdose and transcardially perfused with ice cold dissection artificial cerebrospinal fluid (ACSF)50 or 
directly decapitated, respectively. 350 μm-thick (MF recordings) or 300 µm-thick (CA3-CA1 recordings) hip-
pocampal sections were incubated at 35 °C for 30 minutes immediately after preparation and kept in a resting 
chamber at 22–24 °C (MF recordings) or at RT (CA3-CA1 recordings) for at least an hour before use. A detailed 
description of all the electrophysiological experiments is found in the Supplemental Information.
Statistic. Statistic was performed with IBM SPSS Statistics version 25 (IBM) or with GraphPad Prism 
(GraphPad). Data distribution was assessed by Kolmogorov-Smirnov normality test and by inspecting histo-
grams and normality Q-Q plots. Data were analyzed with one-way ANOVA followed by Tukey post-hoc test or by 
Kruskal-Wallis test followed by Mann Whitney U test, Bonferroni corrected with α set to 0.016667 to account for 
multiple comparisons, unless otherwise stated. Only two tail p-values were considered. Values are expressed as 
mean ± SEM, n indicates the number of boutons analyzed for EM analysis or the number of brain slices for elec-
trophysiological experiments, unless otherwise stated. A detailed description of the statistical analysis is found in 
the Supplemental Information.
Data availability
The data that supports the findings of this study are available from the corresponding authors (VH and SJS) upon 
reasonable request.
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